Cooperative Agreement U01DA059695
Award Date
9/15/24
Completion Date
5/31/29
Dollars Obligated
$2.1M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Cooperative Agreement
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This federal Project Grant award of $357,613 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to identify novel rare and common genetic variants associated with substance use disorders (SUDs) and enhance disease prediction through a whole-genome multi-ancestry polygenic risk score framework. The research, conducted by Yale University, aims to leverage large-scale whole-genome sequencing datasets to address...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $715,238.00 to the University of California, San Diego (UCSD) to conduct a multivariate genome-wide association analysis of opioid-related traits in a diverse population of 500,000 individuals. The goal is to improve understanding of the genetic basis of opioid use disorder (OUD) and related pre-addiction stages, such as initial opioid use,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This Project Grant award of $2,811,343, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the "Center for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats" at the University of California, San Diego (UCSD). The award will fund critical core services to maintain two heterogeneous stock (HS) rat breeding colonies and provide genotyping, data analysis, and pilot project support...
This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $944,888 to Seattle Children's Hospital (dba Seattle Children's Research Institute) to conduct a deep analysis of the transcriptome in rats to understand the genetics of substance use disorders (SUDs). The 5-year project aims to expand integrative genome and transcriptome analysis to study a wide range of transcriptional phenotypes,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is providing $174,029.99 to the University of California, Irvine to investigate the role of the GILZ gene in regulating cocaine-induced cellular activity and cocaine-associated memory formation. The research aims to elucidate how the GILZ gene, which is located on the X chromosome, may contribute to sex-dependent differences in responses to...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $438,750 to the University of California, San Diego (UCSD) to investigate pre-existing differences in GABAergic and glutamatergic transmission within the central amygdala and their potential contribution to individual differences in cocaine addiction susceptibility. The study aims to characterize and compare basal GABAergic and...
This federal Project Grant award of $811,112 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research by the University of California, San Francisco (UCSF) to investigate the brain networks and neural signaling mechanisms that underlie sudden "insight" learning of cue-reward associations. The key objectives are to use advanced techniques like two-photon calcium imaging, high-density...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $272,395 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the biochemical mechanisms of the G9A/GLP histone methyltransferases and their role in the development of addictive behaviors. The key objectives of this 2-year award, which runs from April 2025 to March 2027, are to: 1) identify specific...
The University of Hawaii (UH) at Manoa received a $218,250 Project Grant award from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The award will fund research to characterize the genetic risks associated with methamphetamine use disorder, with a focus on identifying how genetic variants in the L-type calcium channel gene may influence brain inflammation, neuronal function, and cognitive...